{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:18:27Z","timestamp":1788895107446,"version":"build-2803163510"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T00:00:00Z","timestamp":1384819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0080657","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T17:02:38Z","timestamp":1384880558000},"page":"e80657","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Targeting of Histone Deacetylases to Reactivate Tumour Suppressor Genes and Its Therapeutic Potential in a Human Cervical Cancer Xenograft Model"],"prefix":"10.1371","volume":"8","author":[{"given":"Dingqing","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,19]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2217\/epi.10.1","article-title":"Epigenetic targets in human neoplasms","volume":"2","author":"TE Fandy","year":"2010","journal-title":"Epigenomics"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1101\/gr.118919.110","article-title":"Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer","volume":"22","author":"F Valdes-Mora","year":"2012","journal-title":"Genome Res"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.drup.2012.01.008","article-title":"Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance","volume":"15","author":"RH Wilting","year":"2012","journal-title":"Drug Resist Updat"},{"key":"ref4","first-page":"1596","article-title":"Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy","volume":"9","author":"B Segura-Pacheco","year":"2003","journal-title":"Clin Cancer Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1158\/1940-6207.CAPR-10-0039","article-title":"Global reactivation of epigenetically silenced genes in prostate cancer","volume":"3","author":"I Ibragimova","year":"2010","journal-title":"Cancer Prev Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"L Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","article-title":"Histone deacetylase inhibitors: molecular mechanisms of action","volume":"26","author":"WS Xu","year":"2007","journal-title":"Oncogene"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1128\/MCB.23.21.7719-7731.2003","article-title":"Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition","volume":"23","author":"H Siddiqui","year":"2003","journal-title":"Mol Cell Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1038\/sj.onc.1210178","article-title":"Epigenetic patterns of the retinoic acid receptor beta2 promoter in retinoic acid-resistant thyroid cancer cells","volume":"26","author":"A Cras","year":"2007","journal-title":"Oncogene"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e58267","DOI":"10.1371\/journal.pone.0058267","article-title":"Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells","volume":"8","author":"A Laurenzana","year":"2013","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/ijc.27316","article-title":"Cellular senescence and tumor suppressor gene p16","volume":"130","author":"H Rayess","year":"2012","journal-title":"Int J Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1470-2045(05)70319-3","article-title":"Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer","volume":"6","author":"J Abu","year":"2005","journal-title":"Lancet Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00784-010-0388-8","article-title":"Altered expression of cell-cell adhesion molecules beta-catenin\/E-cadherin and related Wnt-signaling pathway in sporadic and syndromal keratocystic odontogenic tumors","volume":"15","author":"SG Hakim","year":"2011","journal-title":"Clin Oral Investig"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"567305","DOI":"10.1155\/2011\/567305","article-title":"E-cadherin\/beta-catenin complex and the epithelial barrier","volume":"2011","author":"X Tian","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial-mesenchymal transition during tumor progression","volume":"17","author":"MA Huber","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/modpathol.2009.160","article-title":"Upregulation of vimentin and aberrant expression of E-cadherin\/beta-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome","volume":"23","author":"LK Liu","year":"2010","journal-title":"Mod Pathol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/sj.onc.1208286","article-title":"Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo","volume":"24","author":"F Fazi","year":"2005","journal-title":"Oncogene"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1158\/1535-7163.MCT-04-0079","article-title":"Valproic acid, in combination with all-trans retinoic acid and 5-aza-2\u2032-deoxycytidine, restores expression of silenced RARbeta2 in breast cancer cells","volume":"4","author":"NP Mongan","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/156652412799218949","article-title":"Combination of valproic acid and ATRA restores RARbeta2 expression and induces differentiation in cervical cancer through the PI3K\/Akt pathway","volume":"12","author":"D Feng","year":"2012","journal-title":"Curr Mol Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.humpath.2011.08.025","article-title":"Significance of E-cadherin, beta-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma","volume":"43","author":"Y Cheng","year":"2012","journal-title":"Hum Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/bjc.1996.236","article-title":"Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues","volume":"73","author":"X Chui","year":"1996","journal-title":"Br J Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/modpathol.2011.50","article-title":"Interobserver variability of laryngeal mucosal premalignant lesions: a histopathological evaluation","volume":"24","author":"SA Fleskens","year":"2011","journal-title":"Mod Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e1003397","DOI":"10.1371\/journal.pgen.1003397","article-title":"Nuclear myosin 1c facilitates the chromatin modifications required to activate rRNA gene transcription and cell cycle progression","volume":"9","author":"A Sarshad","year":"2013","journal-title":"PLoS Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0145-2126(01)00151-5","article-title":"Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways","volume":"26","author":"R Kawagoe","year":"2002","journal-title":"Leuk Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e49692","DOI":"10.1371\/journal.pone.0049692","article-title":"Role of histone deacetylases in gene regulation at nuclear lamina","volume":"7","author":"BC Milon","year":"2012","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.bcp.2006.12.032","article-title":"Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines","volume":"73","author":"JN Ou","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/01635581.2011.605982","article-title":"Promoter methylation of E-cadherin, p16, and RAR-beta(2) genes in breast tumors and dietary intake of nutrients important in one-carbon metabolism","volume":"63","author":"MH Tao","year":"2011","journal-title":"Nutr Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"627840","DOI":"10.1155\/2009\/627840","article-title":"Studies on Multifunctional Effect of All-Trans Retinoic Acid (ATRA) on Matrix Metalloproteinase-2 (MMP-2) and Its Regulatory Molecules in Human Breast Cancer Cells (MCF-7)","volume":"2009","author":"A Dutta","year":"2009","journal-title":"J Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ydbio.2011.10.018","article-title":"Mesodermal retinoic acid signaling regulates endothelial cell coalescence in caudal pharyngeal arch artery vasculogenesis","volume":"361","author":"P Li","year":"2012","journal-title":"Dev Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3835(97)00475-8","article-title":"Differentiation and antiproliferation effects of retinoic acid receptor beta in hepatoma cells","volume":"124","author":"C Li","year":"1998","journal-title":"Cancer Lett"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"32856","DOI":"10.1074\/jbc.M506119200","article-title":"Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death","volume":"280","author":"E Calautti","year":"2005","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1038\/jid.2010.99","article-title":"Reduced aquaporin3 expression and survival of keratinocytes in the depigmented epidermis of vitiligo","volume":"130","author":"NH Kim","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1242\/jcs.101931","article-title":"Plakoglobin-dependent regulation of keratinocyte apoptosis by Rnd3","volume":"125","author":"KR Ryan","year":"2012","journal-title":"J Cell Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/35895","article-title":"Role of the histone deacetylase complex in acute promyelocytic leukaemia","volume":"391","author":"RJ Lin","year":"1998","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/leu.2012.39","article-title":"Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL","volume":"26","author":"M Leiva","year":"2012","journal-title":"Leukemia"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e54873","DOI":"10.1371\/journal.pone.0054873","article-title":"Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers","volume":"8","author":"MB Raeder","year":"2013","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1158\/1078-0432.CCR-13-0312","article-title":"A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors","volume":"19","author":"B Venugopal","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-4598-4-22","article-title":"Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study","volume":"4","author":"A Chavez-Blanco","year":"2005","journal-title":"Mol Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/bjh.12332","article-title":"A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy","volume":"161","author":"G Finazzi","year":"2013","journal-title":"Br J Haematol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2217\/fon.12.173","article-title":"Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials","volume":"9","author":"T Qiu","year":"2013","journal-title":"Future Oncol"},{"key":"ref41","first-page":"718","article-title":"Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms","volume":"8","author":"V Sandor","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/156800912799095135","article-title":"Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancer","volume":"12","author":"S Tan","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1479-5876-4-55","article-title":"Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid","volume":"4","author":"L Mora-Garcia Mde","year":"2006","journal-title":"J Transl Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"9751","DOI":"10.1073\/pnas.0710413105","article-title":"Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation","volume":"105","author":"CK Hahn","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"8903","DOI":"10.1158\/0008-5472.CAN-05-2726","article-title":"Sequential valproic acid\/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia","volume":"66","author":"G Cimino","year":"2006","journal-title":"Cancer Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bjc.2011.527","article-title":"Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours","volume":"106","author":"R Pili","year":"2012","journal-title":"Br J Cancer"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/bjc.2012.8","article-title":"The MEK1\/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models","volume":"106","author":"SV Holt","year":"2012","journal-title":"Br J Cancer"},{"key":"ref48","first-page":"4287","article-title":"Experimental model for combination chemotherapy with metronidazole using human uterine cervical carcinomas transplanted into nude mice","volume":"40","author":"H Tokita","year":"1980","journal-title":"Cancer Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1158\/1078-0432.CCR-04-1155","article-title":"Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model","volume":"11","author":"SE Touma","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"37521","DOI":"10.1074\/jbc.M110.132795","article-title":"Interactive roles of Ets-1, Sp1, and acetylated histones in the retinoic acid-dependent activation of guanylyl cyclase\/atrial natriuretic peptide receptor-A gene transcription","volume":"285","author":"P Kumar","year":"2010","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.canlet.2009.05.019","article-title":"Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells","volume":"285","author":"H Tatebe","year":"2009","journal-title":"Cancer Lett"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cell.2007.02.050","article-title":"Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors","volume":"129","author":"TT Schug","year":"2007","journal-title":"Cell"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2009.04.043","article-title":"Genomic antagonism between retinoic acid and estrogen signaling in breast cancer","volume":"137","author":"S Hua","year":"2009","journal-title":"Cell"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0080657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T01:31:28Z","timestamp":1647135088000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0080657"}},"subtitle":[],"editor":[{"given":"Joseph","family":"Najbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,19]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0080657","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,19]]}}}